Cita APA (7a ed.)

Velcheti, V., Hu, X., Piperdi, B., & Burke, T. (2021). Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices. Nature Portfolio.

Cita Chicago Style (17a ed.)

Velcheti, Vamsidhar, Xiaohan Hu, Bilal Piperdi, y Thomas Burke. Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC at US Oncology Practices. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Velcheti, Vamsidhar, et al. Real-world Outcomes of First-line Pembrolizumab Plus Pemetrexed-carboplatin for Metastatic Nonsquamous NSCLC at US Oncology Practices. Nature Portfolio, 2021.